Despite its success in advanced melanoma, Bristol Myers Squibb’s fixed-dose PD-1/LAG-3 combo, Opdualag, failed to move the ...

Adjuvant nivolumab offered sustained survival benefits in resected esophageal/GEJ cancer post chemoradiation, with PD-L1 ...

Preclinical and observational studies suggest that exercise may improve cancer outcomes. However, definitive level 1 evidence ...

In the United States, approximately 55% of resected gallbladder cancer (GBC) patients undergo oncologic surgery without ...

Adding nivolumab to chemoradiotherapy may reduce recurrence in patients with resected high-risk head and neck cancer, ...

值此契机，丁香园特邀QEELIN 研究的两位 Leading PI —— 中国医学科学院肿瘤医院石远凯教授与中山大学肿瘤防治中心张兰军教授，深度解读该研究开展的初衷与背景、关键数据及临床实践指导意义。

The Alliance for Clinical Trials in Oncology has announced results from ATOMIC, a Phase III trial evaluating standard ...

A three year structured exercise programme reduced the relative risk of disease recurrence, new primary cancer, or death by 28% in patients with stage 3 and high risk stage 2 colon cancer, a phase 3 ...

Cerebrospinal fluid derived ctDNA and CTC based molecular analysis highlighting the sampling proximity for clinical significance. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.

Diagnostic properties of a novel ctDNA assay for lung cancer detection. Tumor type prediction via tissue- and liquid-based comprehensive genomic profiling: High-specificity tobacco signature detection ...

The addition of postsurgical atezolizumab immunotherapy to standard-of-care chemotherapy in patients with stage III deficient ...

About 15% of colon cancers are dMMR, which confers resistance to chemotherapy. ICIs have FDA approval for metastatic dMMR ...